A mouse study has demonstrated that glioblastoma could be treated directly using an ultrasound technique that delivers a potent treatment across the blood–brain barrier into the tumor.
A blood test that measures the amount of cfDNA has been indicated to be correlated with how patients will progress following a glioblastoma diagnosis.
A blood test for glioblastoma may be on the horizons, as researchers identify novel biomarkers that could be used for diagnosis.
A Phase I clinical trial presents veledimex – a drug-inducible gene therapy approach – as a promising treatment technique for glioblastoma.
Enrollment in all ongoing Depatux-M studies has been halted for newly diagnosed glioblastoma due to lack of survival benefit.
We had the pleasure of speaking with Manmeet Ahluwalia about current vaccine options for glioblastoma, including a survivin vaccine (SurVaxM) for newly diagnosed glioblastoma.
Researchers have discovered administering pembrolizumab before surgery is more effective for the treatment of recurrent glioblastoma, than when administering the drug afterwards.
In this interview, we spoke with Justin Lathia about sexual dimorphism in glioblastoma, including his talk on sex differences in microglia and the glioma microenvironment.
This week we look at NurOwn® for multiple sclerosis, a combination therapy failing to meet primary endpoint for glioblastoma and warnings from the US FDA.
A valuable cache of brain cancer biomedical data, termed REMBRANDT, has been made freely accessible to researchers worldwide.